NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional)
ID: 343420Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/343420

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-22-231.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the R21 grant under the funding announcement titled "NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity." This grant aims to support exploratory and developmental research projects that align with the 2022-2026 National Institute of Nursing Research (NINR) Strategic Plan, focusing on holistic approaches to health and addressing critical health challenges through innovative and rigorous study designs. The funding opportunity emphasizes the importance of advancing health equity and promoting effective healthcare solutions, with a maximum budget of $275,000 available over two years. Interested applicants, including higher education institutions and nonprofit organizations, must submit their proposals by May 7, 2025, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-22-231.html
    The Department of Health and Human Services announces the NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity, seeking R21 exploratory/developmental grant applications. This funding aims to support innovative nursing research aligned with the 2022-2026 NINR Strategic Plan, focusing on holistic approaches to health, equity, and evidence-informed practices that tackle critical health challenges. Key aspects include a maximum budget of $275,000 over two years, with specific deadlines for application submissions every few months until May 2025. Eligible applicants include higher education institutions, nonprofits, and government entities, while diverse perspectives in research are encouraged through a Plan for Enhancing Diverse Perspectives (PEDP). Research should follow guiding principles prioritizing inclusion, innovation, and the elimination of health disparities. Applications not meeting specific criteria, such as studies concerning animal models or pharmacological interventions, will be deemed non-responsive. Review criteria emphasize significance, innovation, approach, investigator qualifications, and overall impact. The NIH peer review system will assess scientific merit and allocate funds based on program relevancy and availability. This initiative underscores the government's commitment to advancing health equity and promoting effective, research-driven healthcare solutions across diverse populations.
    Similar Opportunities
    NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting R01 grant applications aimed at advancing nursing research to optimize health and promote health equity, as outlined in the 2022-2026 National Institute of Nursing Research (NINR) Strategic Plan. Applicants are encouraged to propose innovative, context-driven solutions that address significant health challenges, focusing on holistic health understanding and incorporating various research lenses such as health equity and social determinants of health. This initiative emphasizes the importance of inclusive research and aims to enhance health outcomes and policy, with no cost-sharing requirements and a submission deadline of May 7, 2025. Interested applicants can find more information and application guidelines at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Notice of Intent to Publish a Funding Opportunity Announcement for NINR Areas of Emphasis for Research to Optimize Health for All (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) titled "NINR Areas of Emphasis for Research to Optimize Health for All (R21 Clinical Trial Optional)." This funding opportunity aims to support research initiatives that focus on optimizing health outcomes across diverse populations, encouraging meaningful collaborations and innovative project proposals from the research community. The anticipated funding will utilize the R21 grant mechanism, with no cost-sharing or matching requirements, and is categorized under health-related activities. Key dates include the estimated synopsis post date on January 8, 2025, a closing date of February 16, 2025, and an estimated award date of December 1, 2025. Interested applicants should prepare to submit their proposals in alignment with the outlined objectives and timelines.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)." This initiative aims to support new investigators from diverse and underrepresented backgrounds in biomedical research, enabling them to conduct small-scale projects that align with the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other participating institutes. The grants, with a maximum budget of $125,000 per year for a project period not exceeding three years, are intended to facilitate the transition of these researchers toward independence while addressing health disparities. Interested applicants must demonstrate that they have had less than $125,000 in direct costs from combined active research funding and can submit proposals starting in early 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-097.html.
    Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)," aimed at supporting studies that address barriers to the adoption and sustainability of evidence-based health interventions, particularly in underserved communities. The initiative encourages research that promotes equitable access to effective practices and explores methods for discontinuing ineffective or harmful interventions, emphasizing the importance of contextual factors and multidisciplinary collaboration. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with a maximum funding amount of $275,000 and a project period of up to two years. Interested parties can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by May 7, 2025.
    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) to support innovative early-stage research projects that may lead to significant advancements in biomedical, behavioral, or clinical fields. This grant is designed to encourage high-risk, high-reward research, providing funding for projects that are distinct from traditional R01 grants, with a maximum budget of $275,000 over a two-year period, and no more than $200,000 in any single year. Eligible applicants include a wide range of organizations such as educational institutions, nonprofit organizations, and tribal governments, with applications undergoing a rigorous peer review process to assess their innovation and feasibility. Interested parties should note that the application submission period begins on January 16, 2025, with the opportunity closing on January 7, 2028; for further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for NINR Areas of Emphasis for Research to Optimize Health for All (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) titled "NINR Areas of Emphasis for Research to Optimize Health for All (R01 Clinical Trial Optional)." This initiative aims to support research projects that enhance health outcomes across diverse populations, encouraging collaborations and innovative approaches in nursing research. The funding opportunity will utilize the R01 activity code, with no cost-sharing or matching requirements, and is categorized under health-related discretionary funding. Interested applicants should note that the synopsis is expected to be posted on January 8, 2025, with a closing date for applications on February 5, 2025, and an estimated award date of December 1, 2025. For further details, potential applicants are encouraged to prepare their proposals in advance of these key dates.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    NIH Exploratory/Developmental Research Project Grant (Parent R21 Basic Experimental Studies with Humans Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Project Grant (Parent R21 Basic Experimental Studies with Humans Required) to support innovative research projects that involve basic experimental studies with human participants. This funding opportunity aims to foster groundbreaking research strategies that can lead to significant advancements in biomedical, behavioral, or clinical research, particularly in understanding fundamental phenomena without immediate application in mind. Grants may be awarded for a total project period of up to two years, with budgets capped at $275,000, and applications are encouraged from a diverse range of eligible applicants, including historically black colleges and universities, faith-based organizations, and other institutions. Interested parties should note that the application deadline is January 7, 2028, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional mechanism, aimed at supporting exploratory and developmental research in cancer diagnosis, treatment, imaging, symptom management, and prevention. This grant is designed to encourage innovative studies that challenge existing paradigms and address critical barriers in cancer research, particularly focusing on reducing disparities among underserved populations. Eligible applicants include a wide range of organizations, such as historically black colleges, tribal governments, and faith-based organizations, with a maximum funding amount of $275,000 available over a two-year period. Interested parties can find more information and application details at the provided link, with a submission deadline of July 1, 2025, and inquiries directed to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.